Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibody
Here, using the K18-hACE2 transgenic mice model, the authors report the in vivo efficacy of a fully human neutralizing antibody against SARS-CoV-2 and show that when administered before or up to 3 days post infection, treated mice do not exhibit disease symptoms while 80% of control animals succumb...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/46809b3d714542f1b041f07ea3d49be0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:46809b3d714542f1b041f07ea3d49be0 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:46809b3d714542f1b041f07ea3d49be02021-12-02T14:26:44ZPost-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibody10.1038/s41467-021-21239-82041-1723https://doaj.org/article/46809b3d714542f1b041f07ea3d49be02021-02-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-21239-8https://doaj.org/toc/2041-1723Here, using the K18-hACE2 transgenic mice model, the authors report the in vivo efficacy of a fully human neutralizing antibody against SARS-CoV-2 and show that when administered before or up to 3 days post infection, treated mice do not exhibit disease symptoms while 80% of control animals succumb to the infection.Ronit RosenfeldTal Noy-PoratAdva MechalyEfi MakdasiYinon LevyRon AlcalayReut FalachMoshe AftalionEyal EpsteinDavid GurTheodor ChitlaruEinat B. VitnerSharon MelamedBoaz PolitiAyelet ZaubermanShirley LazarAdi Beth-DinYentl EvgyShmuel YitzhakiShmuel C. ShapiraTomer IsraelyOhad MazorNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-9 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Ronit Rosenfeld Tal Noy-Porat Adva Mechaly Efi Makdasi Yinon Levy Ron Alcalay Reut Falach Moshe Aftalion Eyal Epstein David Gur Theodor Chitlaru Einat B. Vitner Sharon Melamed Boaz Politi Ayelet Zauberman Shirley Lazar Adi Beth-Din Yentl Evgy Shmuel Yitzhaki Shmuel C. Shapira Tomer Israely Ohad Mazor Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibody |
description |
Here, using the K18-hACE2 transgenic mice model, the authors report the in vivo efficacy of a fully human neutralizing antibody against SARS-CoV-2 and show that when administered before or up to 3 days post infection, treated mice do not exhibit disease symptoms while 80% of control animals succumb to the infection. |
format |
article |
author |
Ronit Rosenfeld Tal Noy-Porat Adva Mechaly Efi Makdasi Yinon Levy Ron Alcalay Reut Falach Moshe Aftalion Eyal Epstein David Gur Theodor Chitlaru Einat B. Vitner Sharon Melamed Boaz Politi Ayelet Zauberman Shirley Lazar Adi Beth-Din Yentl Evgy Shmuel Yitzhaki Shmuel C. Shapira Tomer Israely Ohad Mazor |
author_facet |
Ronit Rosenfeld Tal Noy-Porat Adva Mechaly Efi Makdasi Yinon Levy Ron Alcalay Reut Falach Moshe Aftalion Eyal Epstein David Gur Theodor Chitlaru Einat B. Vitner Sharon Melamed Boaz Politi Ayelet Zauberman Shirley Lazar Adi Beth-Din Yentl Evgy Shmuel Yitzhaki Shmuel C. Shapira Tomer Israely Ohad Mazor |
author_sort |
Ronit Rosenfeld |
title |
Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibody |
title_short |
Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibody |
title_full |
Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibody |
title_fullStr |
Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibody |
title_full_unstemmed |
Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibody |
title_sort |
post-exposure protection of sars-cov-2 lethal infected k18-hace2 transgenic mice by neutralizing human monoclonal antibody |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/46809b3d714542f1b041f07ea3d49be0 |
work_keys_str_mv |
AT ronitrosenfeld postexposureprotectionofsarscov2lethalinfectedk18hace2transgenicmicebyneutralizinghumanmonoclonalantibody AT talnoyporat postexposureprotectionofsarscov2lethalinfectedk18hace2transgenicmicebyneutralizinghumanmonoclonalantibody AT advamechaly postexposureprotectionofsarscov2lethalinfectedk18hace2transgenicmicebyneutralizinghumanmonoclonalantibody AT efimakdasi postexposureprotectionofsarscov2lethalinfectedk18hace2transgenicmicebyneutralizinghumanmonoclonalantibody AT yinonlevy postexposureprotectionofsarscov2lethalinfectedk18hace2transgenicmicebyneutralizinghumanmonoclonalantibody AT ronalcalay postexposureprotectionofsarscov2lethalinfectedk18hace2transgenicmicebyneutralizinghumanmonoclonalantibody AT reutfalach postexposureprotectionofsarscov2lethalinfectedk18hace2transgenicmicebyneutralizinghumanmonoclonalantibody AT mosheaftalion postexposureprotectionofsarscov2lethalinfectedk18hace2transgenicmicebyneutralizinghumanmonoclonalantibody AT eyalepstein postexposureprotectionofsarscov2lethalinfectedk18hace2transgenicmicebyneutralizinghumanmonoclonalantibody AT davidgur postexposureprotectionofsarscov2lethalinfectedk18hace2transgenicmicebyneutralizinghumanmonoclonalantibody AT theodorchitlaru postexposureprotectionofsarscov2lethalinfectedk18hace2transgenicmicebyneutralizinghumanmonoclonalantibody AT einatbvitner postexposureprotectionofsarscov2lethalinfectedk18hace2transgenicmicebyneutralizinghumanmonoclonalantibody AT sharonmelamed postexposureprotectionofsarscov2lethalinfectedk18hace2transgenicmicebyneutralizinghumanmonoclonalantibody AT boazpoliti postexposureprotectionofsarscov2lethalinfectedk18hace2transgenicmicebyneutralizinghumanmonoclonalantibody AT ayeletzauberman postexposureprotectionofsarscov2lethalinfectedk18hace2transgenicmicebyneutralizinghumanmonoclonalantibody AT shirleylazar postexposureprotectionofsarscov2lethalinfectedk18hace2transgenicmicebyneutralizinghumanmonoclonalantibody AT adibethdin postexposureprotectionofsarscov2lethalinfectedk18hace2transgenicmicebyneutralizinghumanmonoclonalantibody AT yentlevgy postexposureprotectionofsarscov2lethalinfectedk18hace2transgenicmicebyneutralizinghumanmonoclonalantibody AT shmuelyitzhaki postexposureprotectionofsarscov2lethalinfectedk18hace2transgenicmicebyneutralizinghumanmonoclonalantibody AT shmuelcshapira postexposureprotectionofsarscov2lethalinfectedk18hace2transgenicmicebyneutralizinghumanmonoclonalantibody AT tomerisraely postexposureprotectionofsarscov2lethalinfectedk18hace2transgenicmicebyneutralizinghumanmonoclonalantibody AT ohadmazor postexposureprotectionofsarscov2lethalinfectedk18hace2transgenicmicebyneutralizinghumanmonoclonalantibody |
_version_ |
1718391306599792640 |